Laurus Labs Limited (NSE: LAURUSLABS)
India
· Delayed Price · Currency is INR
559.20
-13.35 (-2.33%)
Dec 20, 2024, 3:30 PM IST
Laurus Labs Revenue
Laurus Labs had revenue of 12.24B INR in the quarter ending September 30, 2024, a decrease of -0.06%. This brings the company's revenue in the last twelve months to 50.53B, down -5.23% year-over-year. In the fiscal year ending March 31, 2024, Laurus Labs had annual revenue of 50.41B, down -16.55%.
Revenue (ttm)
50.53B
Revenue Growth
-5.23%
P/S Ratio
5.97
Revenue / Employee
8.41M
Employees
6,007
Market Cap
301.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 50.41B | -10.00B | -16.55% |
Mar 31, 2023 | 60.41B | 11.05B | 22.39% |
Mar 31, 2022 | 49.36B | 1.22B | 2.54% |
Mar 31, 2021 | 48.14B | 19.82B | 69.99% |
Mar 31, 2020 | 28.32B | 5.40B | 23.55% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLaurus Labs News
- 9 days ago - Mixed trends in November CDRMO exports, prefer Syngene and Neuland Labs over Divis Labs and Laurus Labs - Business Upturn
- 15 days ago - Laurus Bio secures 120 cr investment - The Times of India
- 4 weeks ago - T’gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - The Times of India
- 6 weeks ago - Pharma Sector Stocks: Granules down 1.68%, Akums slips 1.29%, Zydus Life up 0.13%, Aurobindo Pharma gains 0.99% in early trade - Business Upturn
- 2 months ago - Laurus Labs Ltd (BOM:540222) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 2 months ago - Laurus Labs Q2 FY25 Results: Revenue flat, net profit declines 55% YoY - Business Upturn
- 2 months ago - Pharma stocks today: Gland Pharma rises 1.53%, Aurobindo Pharma up 1.38%, while Natco Pharma falls 1.40%, and Laurus Labs down 1.41% - Business Upturn
- 3 months ago - Laurus Labs passes US FDA inspection for API manufacturing facility in Hyderabad - Business Upturn